BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Schüttrumpf L, Marschner S, Scheu K, Hess J, Rietzler S, Walch A, Baumeister P, Kirchner T, Ganswindt U, Zitzelsberger H, Belka C, Maihoefer C. Definitive chemoradiotherapy in patients with squamous cell cancers of the head and neck - results from an unselected cohort of the clinical cooperation group "Personalized Radiotherapy in Head and Neck Cancer". Radiat Oncol 2020;15:7. [PMID: 31906998 DOI: 10.1186/s13014-019-1452-4] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Runge A, Petersson M, Riechelmann H. [Oncolytic virotherapy in head and neck cancer]. Laryngorhinootologie 2022. [PMID: 35977557 DOI: 10.1055/a-1901-9214] [Reference Citation Analysis]
2 Monti Hughes A, Goldfinger JA, Palmieri MA, Ramos P, Santa Cruz IS, De Leo L, Garabalino MA, Thorp SI, Curotto P, Pozzi ECC, Kawai K, Sato S, Itoiz ME, Trivillin VA, Guidobono JS, Nakamura H, Schwint AE. Boron Neutron Capture Therapy (BNCT) Mediated by Maleimide-Functionalized Closo-Dodecaborate Albumin Conjugates (MID:BSA) for Oral Cancer: Biodistribution Studies and In Vivo BNCT in the Hamster Cheek Pouch Oral Cancer Model. Life (Basel) 2022;12:1082. [PMID: 35888170 DOI: 10.3390/life12071082] [Reference Citation Analysis]
3 Adrian G, Carlsson H, Kjellén E, Sjövall J, Zackrisson B, Nilsson P, Gebre-Medhin M. Primary tumor volume and prognosis for patients with p16-positive and p16-negative oropharyngeal squamous cell carcinoma treated with radiation therapy. Radiat Oncol 2022;17:107. [PMID: 35701827 DOI: 10.1186/s13014-022-02074-7] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Riechelmann H, Dejaco D, Steinbichler TB, Lettenbichler-Haug A, Anegg M, Ganswindt U, Gamerith G, Riedl D. Functional Outcomes in Head and Neck Cancer Patients. Cancers (Basel) 2022;14:2135. [PMID: 35565265 DOI: 10.3390/cancers14092135] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Meccariello G, Cammaroto G, Iannella G, De Vito A, Ciorba A, Bianchini C, Corazzi V, Pelucchi S, Vicini C, Capaccio P. Transoral robotic surgery for oropharyngeal cancer in the era of chemoradiation therapy. Auris Nasus Larynx 2022. [DOI: 10.1016/j.anl.2022.01.011] [Reference Citation Analysis]
6 Schoetz U, Klein D, Hess J, Shnayien S, Spoerl S, Orth M, Mutlu S, Hennel R, Sieber A, Ganswindt U, Luka B, Thomsen AR, Unger K, Jendrossek V, Zitzelsberger H, Blüthgen N, Belka C, Unkel S, Klinger B, Lauber K. Early senescence and production of senescence-associated cytokines are major determinants of radioresistance in head-and-neck squamous cell carcinoma. Cell Death Dis 2021;12:1162. [PMID: 34911941 DOI: 10.1038/s41419-021-04454-5] [Reference Citation Analysis]
7 Nakayama M, Ohnishi K, Adachi M, Ii R, Matsumoto S, Nakamura M, Miyamoto H, Hirose Y, Nishimura B, Tanaka S, Wada T, Tabuchi K. Efficacy of the pretreatment geriatric nutritional risk index for predicting severe adverse events in patients with head and neck cancer treated with chemoradiotherapy: Efficacy of the pretreatment Geriatric Nutritional Risk Index for predicting severe adverse events. Auris Nasus Larynx 2021:S0385-8146(21)00232-7. [PMID: 34509306 DOI: 10.1016/j.anl.2021.08.009] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
8 Nehlsen AD, Lehrer EJ, Dickstein DR, Posner MR, Misiukiewicz K, Liu J, Gupta V, Bakst RL, Sharma S. Functional Larynx Preservation in Patients With Locally Advanced Squamous Cell Carcinoma of the Larynx and Hypopharynx Treated With Induction Chemotherapy vs. Concurrent Chemoradiation Alone. Cureus 2021;13:e16310. [PMID: 34405069 DOI: 10.7759/cureus.16310] [Reference Citation Analysis]
9 Ku A, Kondo M, Cai Z, Meens J, Li MR, Ailles L, Reilly RM. Dose predictions for [177Lu]Lu-DOTA-panitumumab F(ab')2 in NRG mice with HNSCC patient-derived tumour xenografts based on [64Cu]Cu-DOTA-panitumumab F(ab')2 - implications for a PET theranostic strategy. EJNMMI Radiopharm Chem 2021;6:25. [PMID: 34383182 DOI: 10.1186/s41181-021-00140-1] [Reference Citation Analysis]
10 Condello M, D'Avack G, Vona R, Spugnini EP, Scacco L, Meschini S. Electrochemotherapy with Mitomycin C Potentiates Apoptosis Death by Inhibiting Autophagy in Squamous Carcinoma Cells. Cancers (Basel) 2021;13:3867. [PMID: 34359775 DOI: 10.3390/cancers13153867] [Reference Citation Analysis]
11 Yver CM, Shimunov D, Weinstein GS, Rajasekaran K, Cannady SB, Lukens JN, Lin A, Swisher-McClure S, Cohen RB, Aggarwal C, Bauml JM, Loevner LA, Newman JG, Chalian AA, Rassekh CH, Basu D, O'Malley BW Jr, Brody RM. Oncologic and survival outcomes for resectable locally-advanced HPV-related oropharyngeal cancer treated with transoral robotic surgery. Oral Oncol 2021;118:105307. [PMID: 33932874 DOI: 10.1016/j.oraloncology.2021.105307] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
12 Chargi N, Wegner I, Markazi N, Smid E, de Jong P, Devriese L, de Bree R. Patterns, Predictors, and Prognostic Value of Skeletal Muscle Mass Loss in Patients with Locally Advanced Head and Neck Cancer Undergoing Cisplatin-Based Chemoradiotherapy. J Clin Med 2021;10:1762. [PMID: 33919607 DOI: 10.3390/jcm10081762] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Riechelmann H, Steinbichler TB, Sprung S, Santer M, Runge A, Ganswindt U, Gamerith G, Dudas J. The Epithelial-Mesenchymal Transcription Factor Slug Predicts Survival Benefit of Up-Front Surgery in Head and Neck Cancer. Cancers (Basel) 2021;13:772. [PMID: 33673269 DOI: 10.3390/cancers13040772] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
14 Dejaco D, Uprimny C, Widmann G, Riedl D, Moser P, Arnold C, Steinbichler TB, Kofler B, Schartinger VH, Virgolini I, Riechelmann H. Response evaluation of cervical lymph nodes after chemoradiation in patients with head and neck cancer - does additional [18F]FDG-PET-CT help? Cancer Imaging 2020;20:69. [PMID: 32993805 DOI: 10.1186/s40644-020-00345-8] [Reference Citation Analysis]